Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Linc-MAF-4 regulates Th1/Th2 differentiation and is associated with the pathogenesis of multiple sclerosis by targeting MAF.
[Cerebrospinal fluid diagnostics in multiple sclerosis].
Multifrequency magnetic resonance elastography of the brain reveals tissue degeneration in neuromyelitis optica spectrum disorder.
The impact of adjusted work conditions and disease-modifying drugs on work ability in multiple sclerosis.
Progressive Multiple Sclerosis.
Patchy white matter hyperintensity in ring chromosome 18 syndrome.
The payer's perspective: What is the burden of MS and how should the patient's perspective be integrated in health technology assessment conducted for taking decisions on access to care and treatment?
Opposite Interplay between PPAR Gamma and Canonical Wnt/Beta-Catenin Pathway in Amyotrophic Lateral Sclerosis.
Characterization of mouse spinal cord vascular network by means of synchrotron radiation X-ray phase contrast tomography.
To fingolimod and beyond: The rich pipeline of drug candidates that target S1P signaling.
What you get from what you see: Parametric assessment of visual processing capacity in multiple sclerosis and its relation to cognitive fatigue.
Protein tyrosine phosphatase SHP-1: resurgence as new drug target for human autoimmune disorders.
Rethinking the importance of paroxysmal and unusual symptoms as first clinical manifestation of multiple sclerosis: They do matter.
Real-life experience with fampridine (Fampyra®) for patients with multiple sclerosis and gait disorders.
Intracellular ion signaling influences myelin basic protein synthesis in oligodendrocyte precursor cells.
Extracellular Vesicles from Vascular Endothelial Cells Promote Survival, Proliferation and Motility of Oligodendrocyte Precursor Cells.
Radiologically isolated syndrome: An update on a rare entity.
Validation of the Oxford Participation and Activities Questionnaire.
Adult anaplastic pilocytic astrocytoma - a diagnostic challenge? A case series and literature review.
Postreading Self-Assessment and CME Test-Preferred Responses.
Factitious Graves' disease due to biotin immunoassay interference - A case and review of the literature.
Vitamin D and Systemic Lupus Erythematosus: Myth or Reality?
Etiological, clinical, and radiological features of longitudinally extensive myelopathy in Chinese patients.
Acute inflammatory demyelinating polyradiculoneuropathy in a newborn infant.
Evaluation of a Fatigue Self-Management Program for People with Multiple Sclerosis.
Pages
« first
‹ previous
…
794
795
796
797
798
799
800
801
802
…
next ›
last »